Exoskeleton for Balance
Improving Mediolateral Walking Balance With an Assistive Exoskeleton
Medical University of South Carolina
21 participants
Apr 15, 2026
INTERVENTIONAL
Conditions
Summary
Many people who have experienced a stroke have deficits in their walking balance. The long-term goal of this research is to develop an exoskeleton that can effectively improve walking balance, thus improving functional mobility.
Eligibility
Inclusion Criteria8
- Evidence of a stroke at least 6 months prior to participation
- Evidence of dysfunction of the paretic lower limb (Fugl-Meyer lower extremity motor score \< 34)
- At least 21 years of age
- Self-reported experience of a fall in the previous year, and/or a fear of falling
- Gait speed of at least 0.2 m/s
- Ability to walk on a treadmill without a cane or walker
- Ability to follow three step commands and communicate with experimenters to answer questions (e.g., regarding their balance confidence)
- Provision of informed consent
Exclusion Criteria8
- Resting blood pressure higher than 220/110 mm Hg
- History of unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living
- Preexisting neurological orders or dementia
- Legal blindness or severe visual impairment
- Presence of neglect
- History of DVT or pulmonary embolism within 6 months
- Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions
- Orthopedic injuries or conditions (e.g., joint replacements) in the lower extremities with the potential to alter the gait pattern
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The participant will not wear an exoskeleton
The participant will wear an exoskeleton with zero impedance
The participant will wear an exoskeleton with low joint impedance
The participant will wear an exoskeleton with medium joint impedance
The participant will wear an exoskeleton with high impedance
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07356011